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http://dx.doi.org/10.1016/j.pedneo.2Background: Respiratory failure is rarely associated with Guillain-Barre´ syndrome (GBS) in
children. The aim of the study was to determine the risk factors of respiratory failure in chil-
dren with GBS to advance management.
Methods: In this retrospective study, the variables that lead to respiratory failure were inves-
tigated in 40 children. The risk factors were compared for 4 children with intubation and 36
without. We also analyzed the specific treatments, including corticosteroids, intravenous
immunoglobulin, plasmapheresis, and clinical status at discharge.
Results: Four (10.0%) of the 40 children with GBS required mechanical ventilation. The need
for mechanical ventilation was significantly related to the Hughes score at nadir (p< 0.001),
respiratory distress (p< 0.001), and hypotension (p< 0.001). Atypical presentation of symp-
toms such as croup, hoarseness, vomiting, ataxia, consciousness disturbance, and previous
event of diarrhea were more predominant in patients younger than 6 years. Disability grades
>3 at discharge were found in 15 patients (37.5%), and there was no mortality in the present
case series.
Conclusions: Respiratory failure in childhood GBS was related to the Hughes score at nadir,
respiratory distress, and hypotension. Atypical presentations of symptoms were more predom-
inant in patients younger than 6 years. The prognosis in our series was good and not related tot of General Pediatrics, Chang Gung Memorial Hospital, 5 Fu-Shin Street, Kweishan 333, Taoyuan,
(C.-T. Wu).
an Pediatric Association. Published by Elsevier Taiwan LLC. All rights reserved.
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296 M.-H. Hu et alprevious events. Understanding the risk factors of severe GBS will provide better treatment
strategies and improve the outcomes.
Copyright ª 2012, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
Respiratory failure is a not uncommon life-threatening
occurrence in pediatric emergency departments.
However, it is rarely associated with Guillain-Barre´
syndrome (GBS), one of the most common causes of
neuromuscular emergencies. GBS is defined as an acute
areflexic paralysis followed by recovery.1 An annual inci-
dence of 0.66 to 1.8 cases per 100,000 has been reported in
patients younger than 18 years.2,3 It may involve bulbar
weakness, respiratory failure, and autonomic nervous
system dysfunction. The prognosis for recovery in patients
with GBS can be favorable, with only minor residual
symptoms; however, the mortality rate ranges from 2% to
12%, and respiratory failure is the most life-threatening
complication of GBS. Approximately one-third of GBS
patients are admitted to an intensive care unit (ICU), and
many require mechanical ventilation.4 During this critical
phase, these patients are at risk of systemic complications
with the potential of substantial morbidity and consequent
mortality.5 Thus, awareness of the risk factors of respira-
tory failure in children with GBS is important to prevent
associated complications and even death.
However, understanding of the clinical symptoms of GBS
in different age groups, especially younger children, are yet
to be fully elucidated. Additionally, the causes of required
assistant ventilation in childhood GBS as well as associated
predictors remain unclear. Therefore, a study of the
predictors associated with respiratory failure and outcome
is needed. The current study analyzed the clinical presen-
tations in GBS patients in different age groups. Moreover,
this study evaluated the predictors of respiratory failure
and outcomes in an effort to improve the therapeutic
strategy for this disease.
2. Patients and Methods
The aim of the present study was to investigate the clinical
features, prognostic factors, and therapeutic results of
patients with GBS who presented in a pediatric emergency
department (PED) or were admitted to our hospital. In
addition, any potential predictors of respiratory failure
were evaluated. This study was approved by the institu-
tional review board of this hospital.
The medical records of patients with GBS presenting in
clinical settings between January 2001 and June 2009 were
reviewed. For the present study, the clinical details for
each patient were recorded, including age, gender, ante-
cedent infections, neurological findings during the course
of treatment, results of cerebrospinal fluid (CSF) analysis,
and specific treatments such as corticosteroids, intravenous
immunoglobulin (IVIG), and plasmapheresis. At the point of
nadir during admission to the hospital, patients weregraded using a disability scale modified from Hughes et al.6
Grade 0 indicates a normal functional state without
neurological deficits; Grade 1 is characterized by minor
symptoms or signs, but being able to do manual work;
Grades 2 and 3 indicate the presence of ambulation without
or with assistance, respectively; Grade 4 indicates that the
patient is chair- or bed-bound; Grade 5 is applied when the
patient requires a mechanical ventilator; and Grade 6
indicates death. Poor short-term outcome was defined by
death or a persistent disability during admission to the
hospital or at time of discharge with a disability grade of 3
or higher. Additionally, the initial reason for an ICU
admission requiring intubation, the presence of bulbar and
autonomic dysfunction (cardiac arrhythmias including sinus
tachycardia, and hypotension, hypertension, gastrointes-
tinal dysmotility, and bladder dysfunction), and the dura-
tion of intubation were reviewed.
The clinical diagnosis of GBS may be supported by
laboratory and electrodiagnostic data. Based on initial
electrophysiological findings, patients were classified as
having acute inflammatory demyelinating polyneuropathy
(AIDP) when there was evidence of demyelination in at
least two tested nerves.7 Other pathological subtypes,
which predominantly involve axons, are acute motor axonal
neuropathy (AMAN) and acute motor and sensory axonal
neuropathy (AMSAN). The criteria for axonal forms of GBS
require that none of the features of AIDP be present,
except that one demyelinating feature is allowed in one
nerve if compound muscle action potential (CMAP) <10% of
the lower limit of normal in at least two tested nerves.8,9
MillereFisher syndrome (MFS), which is characterized by
a triad of ophthalmoplegia, ataxia, and areflexia, was
postulated to be a variant of GBS.
Findings of electrophysiological studies that included
distal motor, sensory, and F-wave latencies, H-wave
latencies, amplitudes of evoked CMAPs and sensory nerve
action potentials, and motor and sensory conduction
velocities were also investigated. The clinical status of the
patients at the time of PED admittance, disabilities at the
time of discharge, and outcome assessment were recorded
in a standardized chart.
Patients were excluded from this study if: (1) pleocy-
tosis with >100 mononuclear leucocytes was present in
the CSF; (2) the patient did not fully meet the criteria for
GBS; (3) conditions such as chronic inflammatory demye-
linating polyneuropathies or central nervous system
disorders with various neurological deficits were present;
or (4) the patient had not participated in electrophysio-
logical testing.
Baseline characteristics and outcomes are presented
descriptively. Chi-square test, Fisher’s exact test, and
ManneWhitney U test were used for comparative analysis.
A p-value of <0.05 was considered to be statistically
significant. Data were analyzed using SPSS version 17.
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The demographic information and clinical characteristics of
40 children (24 males and 16 females) with GBS are shown
in Table 1. The mean age ranged between 1.9 years and 18
years (mean SD, 7.12 4.58). According to the clinical
and electrophysiological findings, 29 patients (72.5%) were
AIDP, 5 patients (12.5%) were AMAN, one patient (2.5%) was
AMSAN, and five patients (12.5%) were MFS.
Seven patients (17.5%) were admitted to the ICU, and
four (10.0%) of the 40 children with GBS required intuba-
tion. The need for assistant ventilation was significantly
related to the Hughes score at nadir (p< 0.001), respiratory
distress (p< 0.001), autonomic dysfunction (pZ 0.002),
hypotension (p< 0.001), consciousness disturbance
(pZ 0.003), and AMSAN (pZ 0.002). In contrast, factors
that were not significantly related to intubation included
age, gender, and previous events for upper respiratory tract
infection. The mean duration from the presentation ofTable 1 Characteristics of 40 children with Guillain-Barre´ synd
Characteristic (Number)
Total
Male gender (24)
Age, year (mean SD)
Initial presenting to PED
Duration from symptoms to disability nadir (mean SD)
Preceding events
Upper respiratory tract infection (28)
Diarrhea (7)
Clinical manifestation
Weakness (38)
Paresthesia (27)
Disability grade at nadir
Respiratory distress (7)
Autonomic dysfunction (10)
Hypotension (3)
Hypertension (7)
Bladder dysfunction (4)
Cranial Nerve palsy
Ptosis or ophthalmoplegia (4)
Blurred vision (6)
Bulbar dysfunction (15)
Chocking (8)
Slurred speech (3)
Hoarseness (7)
Dysphagia (7)
Conscious disturbance (1)
Ataxia (5)
Electrophysiological study
AIDP (29)
AMAN (5)
AMSAN (1)
MFS (5)
AIDPZ acute inflammatory demyelinating polyneuropathy; AMANZ ac
axonal neuropathy; MFSZMillereFisher syndrome; PED indicates pedsymptoms to the disability nadir was 6.71 5.32 days in
patients without intubation and 8 5.77 days in patients
with intubation. The MFS occurred in five children, three
cases initially presented with blurred vision, three cases
with difficult eye movements, and three cases had ataxia,
and none of children with MFS was admitted to ICU or had
respiratory failure.
The mean disability grades at nadir in the two subgroups
were 5 in the intubation group and 2.67 0.93 in the non-
intubation group. Two patients (50%) with AIDP, one (25%)
with AMAN, and one (25%)with AMSAN-typeGBSwere in need
of ventilator support. CSF studies were conducted on 34
patients. The levels for CSF total protein were 76.35
53.85 mg/dl in the ventilator group and 120.67 82.15
mg/dl in the nonventilator group; 29 patients (72.5%)
revealed a cyto-albuminologic dissociation with elevated
protein with minimal or absent pleocytosis.
In our series, the atypical presentation of symptoms such
as croup, hoarseness, vomiting, ataxia, consciousnessrome.
Number (%) p
Nonintubation Intubation
36 (90.0) 4 (10.0)
22 (61.1) 2 (50.0) 0.667
6.88 4.56 9.24 4.78 0.281
17 (47.2) 4 (100.0) 0.108
6.71 5.32 8.00 5.77 0.476
24 (75.0) 4 (100.0) 0.257
7 (20.6) 0 (0.0) 0.315
34 (94.4) 4 (100.0) 0.629
23 (63.9) 4 (100.0) 0.144
2.67 0.93 5.00 0.00 <0.001
3 (8.3) 4 (100.0) <0.001
6 (16.7) 4 (100.0) 0.002
0 (0.0) 3 (75.0) <0.001
5 (13.9) 2 (50.0) 0.071
3 (8.3) 1 (25.0) 0.292
4 (11.4) 0 (0.0) 0.475
6 (16.7) 0 (0.0) 0.376
14 (38.9) 1 (25.0) 0.586
7 (19.4) 1 (25.0) 0.792
3 (8.3) 0 (0.0) 0.548
7 (19.4) 0 (0.0) 0.332
6 (16.7) 1 (25.0) 0.677
0 (0.0) 1 (25.0) 0.003
5 (13.9) 0 (0.0) 0.426
27 (75.0) 2 (50.0) 0.363
4 (11.1) 1 (25.0) 0.426
0 (0.0) 1 (25.0) 0.002
5 (13.9) 0 (0.0) 0.426
ute motor axonal neuropathy; AMSANZ acute motor and sensory
iatric emergency department.
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predominant in patients younger than 6 years. Assistant
mechanical ventilation, paresthesia, bulbar dysfunction,
and autonomic dysfunction and AMAN- type GBS were more
frequently presented in patients older than 6 years of age.
Among variables used for the Fisher’s exact test, the results
revealed that hypertension (p< 0.05) was significantly
predominant in patients older than 6 years.
The mean duration of admission was 15.3 8.7 days for
those patients with good outcome and 19.8 9.5 days for
those who had poor short-term outcome (p< 0.05). Poor
short-term outcome was associated with disability grades
at nadir (p< 0.001). There was no significant difference
between poor and good short-term outcomes in age,
gender, mechanical ventilation, and electrophysiological
findings.
The various therapeutic regimens used in our study were
as follows: two patients received plasmapheresis, and four
patients received only IVIG, whereas 24 patients received
only corticosteroid, and 11 patients were treated concur-
rently with IVIG and corticosteroids. Good outcome at time
of discharge was seen in treatment with plasmapheresis
(50%), IVIG (50.0%), corticosteroids (58.3%), and concur-
rently with IVIG and corticosteroids (72.7%).
The majority of patients (62.5%) had a good outcome at
discharge, and there was no mortality in the present case
series. Disability grades >3 at discharge were found in 15
patients (37.5%), including 12 (41.4%) with AIDP, two
(40.0%) with AMAN, and one (20.0%) with MFS (Table 2). One
patient with AMAN-type GBS who did not respond to IVIG
treatment received the plasmapheresis 16 days after
symptom onset and had a poor outcome.Table 2 Short-term outcomes at discharge of Guillain-Barre´ sy
Characteristic
Good outcome
Total 25 (62.5)
Male gender (24) 9 (60.0)
Age (mean SD) 6.8 4.2
Initial presenting to PED (21) 13 (61.9)
Mechanical ventilation (4) 3 (75.0)
Disability grade at nadir 3.1 1.0
Duration of symptom improved 15.6  10.6
Duration of admission 15.3 8.7
Cerebral spinal fluid protein 119.8 61.6
Treatment
Plasmapheresis (2) 1 (50)
IVIG (4) 2 (50.0)
Corticosteroids (24) 14 (58.3)
IVIG and corticosteroids (11) 8 (72.7)
Electrophysiological study
AIDP (29) 17 (58.6)
AMAN (5) 3 (60.0)
AMSAN (1) 1 (100.0)
MFS (5) 4 (80.0)
AIDPZ acute inflammatory demyelinating polyneuropathy; AMANZ a
axonal neuropathy; IVIGZ intravenous immune globulin; MFSZ
department.4. Discussion
This study examined the clinical presentation of symptoms
in GBS patients of different age groups as well as predictive
factors of respiratory failure in GBS during admission. The
clinical presentation of symptoms in children with GBS was
atypical and differed from that of adult-onset GBS, espe-
cially in children younger than 6 years of age. The diagnosis
of GBS in preschool children is delayed compared to older
children.10 In the current series, three cases initially pre-
sented at the PED with hoarseness and epiglotitis. All of
these patients improved after IVIG.
This study revealed that the predictors of respiratory
failure in childhood GBS were the disability score at nadir,
respiratory distress, and hypotension. The results of
numerous studies in adults indicate that a rapid progression
of motor weakness,4 cranial nerve deficits,11 disability
score at nadir,12,13 and electrophysiological features of
nerve conduction blockage13 are associated with respira-
tory failure in GBS. Our results confirm previous findings
that a high GBS disability score at nadir is associated with
the necessity for mechanical ventilation in GBS
patients.4,12e14
The prognosis for MFS in our case series was good, and
none of the MFS patients required mechanical ventilation.
MFS is the most common clinical variant of GBS and occurs
in about 5% of adult patients.15 This variant is generally
accepted as a form of GBS due to similar neurophysiological
and CSF analysis findings.16 Only a few cases of the MFS
variant have been reported in children, usually with a good
prognosis,17 but one study found that respiratory failure
was 8.6-fold higher compared to that for typical GBS.18ndrome in children.
Number (%) p
Poor outcome
15 (37.5)
15 (60.0) 1.000
7.3 4.8 0.281
8 (38.1) 1.000
1 (25.0) 1.000
2.8 1.2 <0.001
24.33 13.0 0.948
19.8 9. 5 0.047
113.4 88.7 0.364
1 (50) 1.000
2 (50.0) 0.622
10 (41.7) 0.740
3 (27.3) 0.486
12 (41.4) 0.544
2 (40.0) 1.000
0 (0.0) 1.000
1 (20.0) 0.633
cute motor axonal neuropathy; AMSANZ acute motor and sensory
MillereFisher syndrome; PED indicates pediatric emergency
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respiratory failure is good,19 this is an emergency situation
associated with increased morbidity. Major associated
complications of GBS are bedridden status, prolonged
assistant ventilation, pulmonary infections, deep vein
thrombosis, severe arrhythmia, and gastrointestinal
hemorrhage.20 Early recognition and prompt therapy may
decrease the complications in patients with respiratory
failure.
The current study’s results showed that high levels of
Hughes score at nadir, duration of admission, and hypo-
tension were associated with respiratory failure, while age,
gender, and electrophysiological findings did not affect the
short-term outcome. Previous studies of GBS have recog-
nized that several clinical factors are associated with poor
outcome, including a low mean CMAP amplitude, ventilator
dependence, and rapid progression of the illness.21
Both plasmapheresis and IVIG have been documented to
shorten the time necessary for assistant ventilation, and
IVIG may be a form of less invasive management and more
convenient in pediatric patients.22 On the basis of these
findings, combined treatment with IVIG and corticosteroids
is more beneficial compared with the other treatments. In
this case series, the prognosis of the patients was good, and
none of the patients died. Only one case with axonal-type
GBS exhibited prolonged muscle weakness.
The limitations of this study and subsequent analysis are
inherent in its retrospective nature. Because of the small
number of children with GBS in this study, these findings
require further confirmation in a larger series study.5. Conclusion
This study demonstrated that respiratory failure in GBS was
significantly related to the Hughes score at nadir, respira-
tory distress, hypotension, conscious disturbance and
AMSAN. The predictors of respiratory failure in GBS may
help to administer prompt treatment. The prognosis in this
series was good and not related to previous events.
Understanding the risk factors of respiratory failure and
poor outcome of GBS will provide better treatment strat-
egies and improve the outcomes.Acknowledgments
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